Predicting Lipid Changes in Psychiatric Patients on Medication
Author Information
Author(s): Delacrétaz Aurélie, Sadler Marie, Gamma Franziska, Preisig Martin, Richard-Lepouriel Hélène, von Gunten Armin, Conus Philippe, Plessen Kerstin Jessica, Kutalik Zoltan, Eap Chin B.
Primary Institution: Lausanne University Hospital, Lausanne, Switzerland
Hypothesis
Can clinical and genetic factors predict early worsening of lipid levels in patients starting psychotropic treatments?
Conclusion
Clinical and genetic factors can help predict early worsening of lipid levels and new-onset dyslipidaemia in psychiatric patients starting at-risk psychotropic treatments.
Supporting Evidence
- 44% of patients experienced early increases in total cholesterol levels.
- Adding genetic data improved predictive models significantly.
- Low baseline lipid levels were risk factors for early worsening.
Takeaway
This study found that doctors can use both health information and genetic tests to better predict if patients will have problems with their cholesterol when they start certain medications.
Methodology
The study evaluated clinical characteristics and genetic factors in three samples of psychiatric patients to predict early worsening of lipid levels.
Potential Biases
Potential bias due to the exclusion of non-adherent patients and the focus on a specific ethnic group.
Limitations
The study included only White patients, most participants were not drug-naïve, and lifestyle factors were not accounted for.
Participant Demographics
Median age was 41 years, with a majority diagnosed with psychotic disorders.
Statistical Information
P-Value
p ≤ 0.00003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website